ClinicalTrials.govpublic full text
Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
leukemia, lymphoma, non-hodgkin, hodgkin disease, myelodysplastic syndromes, multiple myeloma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 834808
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.